MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Investor.lilly.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Investor.lilly.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Investor.lilly.com most likely does not offer any adult content.
Popular pages
-
Investors | Eli Lilly and Company
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
-
Quarterly Results | Eli Lilly and Company
Call (800) 545-5979
-
Individual Investors | Eli Lilly and Company
Dividend Reinvestment and Stock Purchase Plans (DRIP) EQ Shareowner Services administers the Shareowner Service Plus Plan, which allows registered shareholders to purchase additional shares of Lilly c...
-
Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements
Revenue in Q4 2022 decreased 9%. Excluding COVID-19 antibodies, revenue in Q4 2022 increased 5%, or 10% on a constant currency basis, driven by volume growth of key growth products, partially offset b...
-
Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress | Eli Lilly
Europe and the submission of lebrikizumab U.S. and European Union. Key growth products - consisting of Verzenio, Trulicity, Mounjaro, Jardiance, Taltz, Emgality, Retevmo, Cyramza, Tyvyt and Olumian...
-
Interactive Financials | Eli Lilly and Company
Year Ending Dec 2021 (Update) Year Ending Dec 2020 (Update) Year Ending Dec 2019 (Update) Year Ending Dec 2018 (Restated) ...